Financial Services
Shanrong Biotechnology Corp.(SRBT)
Live Price
Offline$0.0001
+0.00% today
1Y Change
-99.98%
Window
Jun 20, 2025 → Jun 17, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- -43.5%
- Dividend Yield
- 0.0%
Coverage: 250 bars · Jun 20, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Shanrong Biotechnology Corp. (SRBT) is a Financial Services stock with listed on OTC. The stock last traded around $0.00 and down 100.0% across the available one-year price window (Jun 20, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -43.5%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -43.5%, free cash flow 0.0% with operating margin 0.0% and ROIC 93.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRBT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Below sector median
0.0% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -43.5%, with operating margin around 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRBT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SRBT Max Drawdown
-99.98%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SRBT and SPY.
Company Overview
Shanrong Biotechnology Corp.
Other OTC
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services. It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Beverly Hills, California.
- Leadership
- Colonel Timothy D. Ringgold
- IPO Date
- Feb 9, 2018
- Employees
- 3
- Street Address
- 9350 Wilshire Boulevard
- Mailing
- Beverly Hills, CA, 90212
- Region
- Beverly Hills, CA, US
- Reporting Currency
- USD
- Investor Line
- 310-359-6895
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- 0.1
- Price/Sales
- —
- Price/Book
- —
Growth
- Revenue
- 0.0%
- EPS
- -43.5%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 6.4%
- ROIC
- 93.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.07
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.